Company Filing History:
2 out of 20 
2 out of 4 
1 out of 155 
Years Active: 2015-2017
Title: Susanne Kleber: Innovator in Glioblastoma Treatment
Introduction
Susanne Kleber is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of high-grade glioblastoma multiforme. With a total of three patents to her name, her work focuses on innovative methods to combat this aggressive form of brain cancer.
Latest Patents
One of her latest patents is titled "Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo." This invention relates to methods for treating individuals with high-grade glioblastoma multiforme by preventing or disrupting the binding of CD95 to its ligand, CD95L, in vivo. The neutralization of CD95 activity is crucial as it reduces undesirable glial cell migration and invasion into body tissue. This innovative approach has the potential to significantly improve treatment outcomes for patients suffering from this challenging condition.
Career Highlights
Throughout her career, Susanne Kleber has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum (German Cancer Research Center) and the Universitätsklinikum Heidelberg. Her research has been instrumental in advancing the understanding and treatment of glioblastoma, showcasing her dedication to improving patient care.
Collaborations
Susanne has collaborated with notable colleagues in her field, including Ignacio Sancho-Martinez and Ana Martin-Villalba. These partnerships have further enriched her research and contributed to the development of innovative treatment strategies.
Conclusion
Susanne Kleber's work in glioblastoma treatment exemplifies the impact of innovation in medical research. Her patents and collaborations highlight her commitment to advancing cancer treatment and improving patient outcomes.